{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:18:24Z","timestamp":1793092704892,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jvoice.2019.07.025","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T17:40:10Z","timestamp":1567186810000},"page":"271-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Quality of Life After Botulinum Toxin Injection in Patients With Adductor Spasmodic Dysphonia; a Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"35","author":[{"given":"Maryam","family":"Faham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza Ghaedamini","family":"Harouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payman","family":"Dabirmoghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2019.07.025_bib0001","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/toxins9110356","article-title":"Chemodenervation of the larynx","volume":"9","author":"Kaye","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0002","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s11682-016-9513-x","article-title":"Neural correlates of dystonic tremor: a multimodal study of voice tremor in spasmodic dysphonia","volume":"11","author":"Kirke","year":"2017","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0003","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.anl.2013.10.017","article-title":"Brain activity related to phonation in young patients with adductor spasmodic dysphonia","volume":"41","author":"Kiyuna","year":"2014","journal-title":"Auris Nasus Larynx"},{"issue":"suppl C","key":"10.1016\/j.jvoice.2019.07.025_bib0004","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.parkreldis.2016.02.003","article-title":"Brain structural changes in spasmodic dysphonia: a multimodal magnetic resonance imaging study","volume":"25","author":"Kostic","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0005","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1097\/MLG.0b013e3180de4d63","article-title":"Nonpharmacologic effects of botulinum toxin on the life quality of patients with spasmodic dysphonia","volume":"117","author":"Anari","year":"2007","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0006","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005537-200202000-00004","article-title":"Risk factors and demographics in patients with spasmodic dysphonia","volume":"112","author":"Schweinfurth","year":"2002","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0007","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/000348941112000708","article-title":"Spasmodic dysphonia: onset, course, socioemotional effects, and treatment response","volume":"120","author":"Tanner","year":"2011","journal-title":"Ann OtolRhinol Laryngol"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0008","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/0003489415588557","article-title":"The mayo clinic arizona spasmodic dysphonia experience: a demographic analysis of 718 patients","volume":"124","author":"Patel","year":"2015","journal-title":"Ann Otol, Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0009","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jvoice.2014.03.009","article-title":"Validation of a telephone screening tool for spasmodic dysphonia and vocal fold tremor","volume":"28","author":"Johnson","year":"2014","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0010","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jvoice.2004.07.001","article-title":"Spectral amplitude measures of adductor spasmodic dysphonic speech","volume":"19","author":"Cannito","year":"2005","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0011","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1007\/s00405-014-3129-9","article-title":"Vocal outcome after endoscopic thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia","volume":"271","author":"Gandhi","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0012","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jvoice.2010.07.011","article-title":"A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia","volume":"26","author":"Morzaria","year":"2012","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvoice.2012.05.005","article-title":"Perceptual structure of adductor spasmodic dysphonia and its acoustic correlates","volume":"26","author":"Cannito","year":"2012","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0014","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/archotol.130.12.1393","article-title":"Perceptual analyses of spasmodic dysphonia before and after treatment","volume":"130","author":"Cannito","year":"2004","journal-title":"Arch Otolaryngol\u2013Head Neck Surg"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0015","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0892-1997(05)80027-X","article-title":"Symptomatology of adductor spasmodic dysphonia: a physiologic model","volume":"6","author":"Izdebski","year":"1992","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0016","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/000348940111000707","article-title":"Evaluation of voice quality in adductor spasmodic dysphonia before and after botulinum toxin treatment","volume":"110","author":"Langeveld","year":"2001","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0017","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jvoice.2000.11.001","article-title":"The impact of long-term botulinum toxin injections on symptom severity in patients with spasmodic dysphonia","volume":"18","author":"Damrose","year":"2004","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0018","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jvoice.2010.08.004","article-title":"Combined modality treatment of adductor spasmodic dysphonia","volume":"26","author":"Silverman","year":"2012","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0019","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000449100","article-title":"Long-term follow-up of patients with spasmodic dysphonia and improved voice despite discontinuation of treatment","volume":"68","author":"Geneid","year":"2016","journal-title":"Folia Phoniatr Logop"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0020","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/lary.24953","article-title":"Longitudinal variations of laryngeal overpressure and voice-related quality of life in spasmodic dysphonia","volume":"125","author":"Yeung","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0021","article-title":"eds. Voice related quality of life in spasmodic dysphonia: a detailed VHI-analysis before and after botulinum treatment","author":"Neumann","year":"2009","journal-title":"Models and Analysis of Vocal Emissions for Biomedical Applications - 6th International Workshop, MAVEBA 2009;"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0022","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s10072-015-2239-5","article-title":"Spasmodic dysphonia follow-up with videolaryngoscopy and voice spectrography during treatment with botulinum toxin","volume":"36","author":"Esposito","year":"2015","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0023","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.baga.2013.08.002","article-title":"Correlation of self-assessment with expert rating and acoustic analysis for spasmodic dysphonia treatment with botulinum neurotoxin A","volume":"3","author":"Hartmann","year":"2013","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0024","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/MLG.0b013e31815e8be0","article-title":"Longitudinal follow-up of adductor spasmodic dysphonia patients after botulinum toxin injection: quality of life results","volume":"118","author":"Paniello","year":"2008","journal-title":"Laryngoscope"},{"issue":"suppl 6)","key":"10.1016\/j.jvoice.2019.07.025_bib0025","first-page":"S1","article-title":"Voice disorders in the workplace: productivity in spasmodic dysphonia and the impact of botulinum toxin","volume":"123","author":"Meyer","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0026","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jcomdis.2005.03.003","article-title":"The consequences of spasmodic dysphonia on communication-related quality of life: a qualitative study of the insider's experiences","volume":"38","author":"Baylor","year":"2005","journal-title":"J Commun Disord"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0027","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1044\/1058-0360.0603.66","article-title":"The voice handicap index (VHI): development and validation","volume":"6","author":"Jacobson","year":"1997","journal-title":"Am J Speech-Lang Pathol"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0028","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/00005537-200409000-00009","article-title":"Development and validation of the voice handicap index\u201010","volume":"114","author":"Rosen","year":"2004","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0029","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0892-1997(99)80010-1","article-title":"Validation of an instrument to measure voice-related quality of life (V-RQOL)","volume":"13","author":"Hogikyan","year":"1999","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1044\/1092-4388(2001\/040)","article-title":"Voice activity and participation profile","volume":"44","author":"Ma","year":"2001","journal-title":"J Speech Lang Hear Res"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0031","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/archotol.127.9.1083","article-title":"Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia","volume":"127","author":"Benninger","year":"2001","journal-title":"Arch Otolaryngol\u2013Head Neck Surg"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0032","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/0194599816675320","article-title":"Effect of botulinum toxin and surgery among spasmodic dysphonia patients","volume":"156","author":"van Esch","year":"2017","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0033","article-title":"Outcome measurement in the treatment of spasmodic dysphonia: a systematic review of the literature","author":"Rumbach","year":"2018","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0034","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1191\/0269215506cr931oa","article-title":"Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review","volume":"20","author":"Watts","year":"2006","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0035","first-page":"112","article-title":"Botulinum toxin injections for the treatment of spasmodic dysphonia","author":"Watts","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0036","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MOO.0000000000000253","article-title":"Review of differential diagnosis and management of spasmodic dysphonia","volume":"24","author":"Whurr","year":"2016","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"suppl1","key":"10.1016\/j.jvoice.2019.07.025_bib0037","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/13682829809179445","article-title":"Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: a review of 22 studies","volume":"33","author":"Whurr","year":"1998","journal-title":"Int J Lang Commun Disorders"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0038","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1044\/1092-4388(2002\/037)","article-title":"Botox treatment in adductor spasmodic dysphonia: a meta-analysis","volume":"45","author":"Boutsen","year":"2002","journal-title":"J Speech Lang Hear Res"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0039","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jvoice.2008.12.014","article-title":"Toward improved ecological validity in the acoustic measurement of overall voice quality: combining continuous speech and sustained vowels","volume":"24","author":"Maryn","year":"2010","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0040","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3109\/02699200903242988","article-title":"Estimating dysphonia severity in continuous speech: application of a multi-parameter spectral\/cepstral model","volume":"23","author":"Awan","year":"2009","journal-title":"Clin Linguist Phon"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0041","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00702-007-0757-x","article-title":"Evidence for the effectiveness of botulinum toxin for spasmodic dysphonia from high-quality research designs","volume":"115","author":"Watts","year":"2008","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0042","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0043","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0044","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00405-011-1890-6","article-title":"Tridimensional assessment of adductor spasmodic dysphonia pre- and post-treatment with Botulinum toxin","volume":"269","author":"Dejonckere","year":"2012","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0045","article-title":"Quality of life and voice changes after a single injection in patients with ADSD over time","author":"Faham","year":"2018","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0046","first-page":"39","article-title":"Voice related quality of life after botulinum toxin injection for spasmodic dysphonia","volume":"131","author":"Gama","year":"2010","journal-title":"Revue de Laryngologie - Otologie - Rhinologie"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0047","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1017\/S0022215111000739","article-title":"The point-touch technique for botulinum toxin injection in adductor spasmodic dysphonia: quality of life assessment","volume":"125","author":"Morzaria","year":"2011","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0048","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/lary.21395","article-title":"Botulinum toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes","volume":"121","author":"Novakovic","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvoice.2016.09.029","article-title":"Vocal parameters and self-perception in individuals with adductor spasmodic dysphonia","volume":"31","author":"Rojas","year":"2017","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/archotol.130.4.415","article-title":"Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia: part II","volume":"130","author":"Rubin","year":"2004","journal-title":"Arch Otolaryngol\u2013Head Neck Surg"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0051","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.14260\/jemds\/2016\/268","article-title":"A study of voice changes in spasmodic dysphonia after botulinum therapy","volume":"5","author":"Singh","year":"2016","journal-title":"J Evol Med Dent Sci-"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0052","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jvoice.2004.03.006","article-title":"Voice handicap index results for older patients with adductor spasmodic dysphonia","volume":"19","author":"Wingate","year":"2005","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0053","unstructured":"Wells G, Shea B, O'connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. 2011. URL: http:\/\/www.ohrica\/programs\/clinical_epidemiology\/oxford.asp. 2016."},{"key":"10.1016\/j.jvoice.2019.07.025_bib0054","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0895-4356(98)00131-0","article-title":"The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus","volume":"51","author":"Verhagen","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0055","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0892-1997(01)00060-1","article-title":"Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia","volume":"15","author":"Hogikyan","year":"2001","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0056","first-page":"1","article-title":"Treatment efficacy of electromyography versus fiberscopy-guided botulinum toxin injection in adductor spasmodic dysphonia patients: a prospective comparative study","volume":"2014","author":"Kim","year":"2014","journal-title":"Sci World J"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0057","series-title":"Effect Sizes for Research. A Broad Practical Approach","author":"Grissom","year":"2005"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0058","first-page":"2006","article-title":"Cochrane handbook for systematic reviews of interventions 4.2.6 [updated September 2006]","volume":"4","author":"Higgins","year":"2006","journal-title":"Cochrane Libr"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0059","first-page":"29","article-title":"Current status of health index in Tehran: a multidimensional approach","volume":"31","author":"Ghaedamini Harouni","year":"2017","journal-title":"Med J Islamic Repub Iran"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0060","series-title":"Methods of meta-analysis: correcting error and bias in research findings","author":"Hunter","year":"2004"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0061","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jvoice.2006.01.007","article-title":"The psychosocial consequences of BOTOX injections for spasmodic dysphonia: a qualitative study of patients' experiences","volume":"21","author":"Baylor","year":"2007","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0062","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jvoice.2015.03.007","article-title":"Behavior assessment battery: a pilot study of the affective, behavioral, and cognitive correlates surrounding spasmodic dysphonia","volume":"30","author":"Vanryckeghem","year":"2016","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0063","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1044\/1092-4388(2001\/040)","article-title":"Voice activity and participation profile: assessing the impact of voice disorders on daily activities","volume":"44","author":"Ma","year":"2001","journal-title":"J Speech Lang Hear Res"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0064","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jvoice.2007.09.001","article-title":"How do individuals cope with voice disorders? introducing the voice disability coping questionnaire","volume":"23","author":"Epstein","year":"2009","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0065","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jvoice.2009.09.007","article-title":"Cross-cultural adaptation and validation of the voice handicap index into Brazilian Portuguese","volume":"25","author":"Behlau","year":"2011","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0066","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0001-6519(07)74954-3","article-title":"Adaptation and validation to the Spanish of the Voice Handicap Index (VHI-30) and its shortened version (VHI-10)","volume":"58","author":"N\u00fa\u00f1ez-Batalla","year":"2007","journal-title":"Acta Otorrinolaringol"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0067","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jvoice.2009.05.006","article-title":"Cross-cultural adaptation and validation of the Voice Handicap Index into Italian","volume":"24","author":"Schindler","year":"2010","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0068","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00043764-200201000-00004","article-title":"Stanford presenteeism scale: health status and employee productivity","volume":"44","author":"Koopman","year":"2002","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0069","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0070","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jvoice.2014.03.017","article-title":"Workplace productivity and voice disorders: a cognitive interviewing study on presenteeism in individuals with spasmodic dysphonia","volume":"28","author":"Isetti","year":"2014","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0071","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1044\/1092-4388(2009\/07-0275)","article-title":"Developing the communicative participation item bank: Rasch analysis results from a spasmodic dysphonia sample","volume":"52","author":"Baylor","year":"2009","journal-title":"J Speech Lang Hear Res"},{"key":"10.1016\/j.jvoice.2019.07.025_bib0072","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1044\/1058-0360(2011\/10-0084)","article-title":"A qualitative study of interference with communicative participation across communication disorders in adults","volume":"20","author":"Baylor","year":"2011","journal-title":"Am J Speech-Lang Pathol"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199719301845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199719301845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:34:33Z","timestamp":1760211273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199719301845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0892199719301845"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2019.07.025","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of Life After Botulinum Toxin Injection in Patients With Adductor Spasmodic Dysphonia; a Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2019.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Voice Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}